Characteristics of HL and B-NHL patients compared with healthy controls
| . | Healthy controls . | HL patients . | B-NHL patients . |
|---|---|---|---|
| N | 11 | 10 | 12 |
| Sex, no. M:F | 7:4 | 4:6 | 3:9 |
| Median age, y (range) | 33 (31-36) | 37.5 (23-85) | 57 (38-74) |
| Histology | 5 MC, 5 NS(EBV+ in 3) | 5 FL, 5 DLBCL, 1 MALT, 1 MLBCL | |
| Stage at onset | 4 stage II, 6 stage IV | 5 stage II, 2 stage III, 5 stage IV | |
| Disease status, no. | |||
| Active disease | 2 | 6 | |
| During treatment | 4 | 2 | |
| Tumor free | 4 | 4 | |
| Chronic infectious disease | None | 1 HCV | 2 HBV, 1 HCV, 1 MAC |
| . | Healthy controls . | HL patients . | B-NHL patients . |
|---|---|---|---|
| N | 11 | 10 | 12 |
| Sex, no. M:F | 7:4 | 4:6 | 3:9 |
| Median age, y (range) | 33 (31-36) | 37.5 (23-85) | 57 (38-74) |
| Histology | 5 MC, 5 NS(EBV+ in 3) | 5 FL, 5 DLBCL, 1 MALT, 1 MLBCL | |
| Stage at onset | 4 stage II, 6 stage IV | 5 stage II, 2 stage III, 5 stage IV | |
| Disease status, no. | |||
| Active disease | 2 | 6 | |
| During treatment | 4 | 2 | |
| Tumor free | 4 | 4 | |
| Chronic infectious disease | None | 1 HCV | 2 HBV, 1 HCV, 1 MAC |